Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Hemostatic Xerogel Sponge

K-Number: K192671 · 2020-08-28

Decision Date2020-08-28
Product CodeQSY
DecisionSubstantially Equivalent

Device Summary

Hemostatic Xerogel Sponge is the device name listed in this FDA 510(k) record. The listed applicant is Solaplus Biotech Co., Ltd.. It received FDA 510(k) clearance on 2020-08-28 under 510(k) number K192671. The device is classified under product code QSY. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Hemostatic Xerogel Sponge?

Hemostatic Xerogel Sponge is a medical device that received FDA 510(k) clearance on 2020-08-28. The listed applicant is Solaplus Biotech Co., Ltd.. The 510(k) number is K192671.

When did Hemostatic Xerogel Sponge receive FDA 510(k) clearance?

Hemostatic Xerogel Sponge received FDA 510(k) clearance on 2020-08-28, under 510(k) number K192671.

Who is the listed applicant for Hemostatic Xerogel Sponge?

The FDA 510(k) record lists Solaplus Biotech Co., Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Hemostatic Xerogel Sponge?

The FDA product code for Hemostatic Xerogel Sponge is QSY.

Related Devices (Code: QSY)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.